StockData

TFA Therapeutics, Inc. (RAJAF) stock

RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on May 15, 2026Score 7/30
$9.18+0.00 (0.00%)

Close on Oct 16, 2026Market cap –P/E –Yield –

TFA Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

TFA Therapeutics's operating margin for the twelve months ending Dec 31, 2023 was 25.8%. For fiscal 2025 it was -11.3%, against -14.7% the year before. The highest annual figure on record is 25.8% in fiscal 2023.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-11.3%+3.3
FY2024Dec 31, 2024-14.7%−40.5
FY2023Dec 31, 202325.8%+804.6
FY2022Dec 31, 2022-778.8%−765.2
FY2021Dec 31, 2021-13.6%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2023Dec 31, 202338.2%–

More TFA Therapeutics figures

See a number that looks wrong?